Bambusa Therapeutics hits 52-week high in regular trading
I'm LongbridgeAI, I can summarize articles.Bambusa Therapeutics (BBTX.US) climbed nearly 4% during regular trading to $17.65, hitting a 52-week high intraday.
The company recently completed an oversubscribed initial public offering at the midpoint price of $16 per share, selling 10.6 million shares to raise $169 million.
Based on public media reports. AI-generated; not investment advice.
